Skip to main content

Table 1 Patient Clinicopathologic Characteristics (n = 236)

From: Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer

Gender n (%)
 Female 233 (98.7)
 Male >51y 3 (1.3)
Age (Female)
  < 51y 93 (40.0)
  ≥ 51y 140 (60.0)
Age
 20-29 4 (1.7)
 30-39 27 (11.4)
 40-49 55 (23.3)
 50-59 68 (28.8)
 60-69 49 (20.8)
 70-79 25 (10.6)
 80-89 8 (3.4)
Histopathology
 IDC 197 (83.5)
 ILC 16 (6.8)
 Apocrine Carcinoma 5 (2.1)
 Medullary Carcinoma 3 (1.3)
 Mucinous Carcinoma 3 (1.3)
 Basal-like Carcinoma 2 (0.8)
 Tubular Cancer 2 (0.8)
 ILC/Tubulolobular 1 (0.4)
 Tubulolobular 1 (0.4)
 Mixed Carcinoma 1 (0.4)
 Papillary Carcinoma 1 (0.4)
 Infiltrating 1 (0.4)
 Other 3 (1.3)
Grade
 Invasive grade I 22 (9.3)
 Invasive grade II 65 (27.5)
 Invasive grade III 149 (63.1)
Molecular Subtype
 ER+, PR+, HER2+ 41 (17.4)
 ER+, PR+, HER2- 95 (40.3)
 ER+, PR-, HER2- 11 (4.7)
 ER+, PR-, HER2+ 12 (5.1)
 ER-, PR+, HER+ 6 2.5)
 ER-, PR+, HER2- 2 (0.8)
 ER-, PR-, HER2+ 24 (10.2)
 ER-, PR-, HER2- 35 (14.8)
 Equivocal/Not performed 10 (4.2)
Equivocal/Not performed: Lack of result for ER, PR and/or HER2)
Disease Outcome/Follow-Up Status n (%)
 Died From Disease 13 (5.5)
 Died From Other Causes 8 (3.4)
 Overall Died 21 (8.9)
 Alive With Disease 6 (2.5)
 Alive With No Disease 207 (87.7)
 Alive Disease Status Unknown 2 (0.8)
 Overall Alive 215 (91.1)